Close Menu

NEW YORK ─ Mount Sinai Health System researchers said on Monday that they have identified cytokine protein inflammation markers that predict the severity of COVID-19 and the likelihood that a coronavirus patient will survive.

The findings provide a foundation for a diagnostic platform and therapeutic targets, the group said in a study published in Nature Medicine. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.